Back
Ionis Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
IONS
Sponsored
7 Stocks to Own Before the 2024 Election
Click the link below to get your copy. FREE
Sell
50
IONS
Ionis Pharmaceuticals
Last Price:
46.08
Seasonality Move:
7%
7 Day Trial
ALL ACCESS PASS
$
7
Free video reveals how to trade 1-day options
Get the free overnight options training here.Ionis Pharmaceuticals Price Quote
$46.08
-0.01 (1.05%)
(Updated: July 6, 2024 at 5:46 AM ET)
Ionis Pharmaceuticals Key Stats
Sell
50
Ionis Pharmaceuticals (IONS)
is a Sell
Day range:
$45.35 - $46.34
52-week range:
$35.95 - $54.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.54
P/B ratio:
22.69%
Volume:
623.6K
Avg. volume:
1.4M
1-year change:
9.24%
Market cap:
$6.7B
Revenue:
$787.6M
EPS:
$-2.67
How Much Does Ionis Pharmaceuticals Make?
-
How Much Are Ionis Pharmaceuticals's Sales Annually?
IONS Revenues are $787.6M -
How Much Profit Does Ionis Pharmaceuticals's Make A Year?
IONS net income is -$366.3M
Is Ionis Pharmaceuticals Growing As A Company?
-
What Is Ionis Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.08% -
What Is Ionis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ionis Pharmaceuticals Stock Price Performance
-
Did Ionis Pharmaceuticals Stock Go Up Last Month?
Ionis Pharmaceuticals share price went up by 15.6% last month -
Did IONS's Share Price Rise Over The Last Year?
IONS share price rose by 9.24% over the past 1 year
What Is Ionis Pharmaceuticals 52-Week High & Low?
-
What Is Ionis Pharmaceuticals’s 52-Week High Share Price?
Ionis Pharmaceuticals has traded as high as $54.44 over the past 52 weeks -
What Is Ionis Pharmaceuticals’s 52-Week Low Share Price?
Ionis Pharmaceuticals has traded as low as $35.95 over the past 52 weeks
Ionis Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ionis Pharmaceuticals?
-
How Much Debt Does Ionis Pharmaceuticals Have?
Total long term debt quarterly is $1.3B -
How Much Cash Does Ionis Pharmaceuticals Have?
Cash and short term investments quarterly total is $2.2B -
What Is Ionis Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.03
Is Ionis Pharmaceuticals Cash Flow Positive?
-
What Is IONS Cash Flow From Operations?
Cash flow from operations (TTM) is -$323.5M -
What Is Ionis Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $175.6M -
What Is Ionis Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $187.6M
Ionis Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
IONS return on invested capital is -23.32% -
What Is Ionis Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -13.23% -
What Is IONS Return On Equity?
ROE is a measure of profitability and is -100.54%
Ionis Pharmaceuticals Earnings Date & Stock Price
-
What Is Ionis Pharmaceuticals's Stock Price Today?
A single share of IONS can be purchased today for 46.09 -
What Is Ionis Pharmaceuticals’s Stock Symbol?
Ionis Pharmaceuticals trades on the nasdaq under the ticker symbol: IONS -
When Is Ionis Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Ionis Pharmaceuticals is scheduled on August 9, 2024 -
When Is IONS's next ex-dividend date?
Ionis Pharmaceuticals's next ex-dividend date is July 8, 2024 -
How To Buy Ionis Pharmaceuticals Stock?
You can buy Ionis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ionis Pharmaceuticals Competitors
-
Who Are Ionis Pharmaceuticals's Competitors?
Below is a list of companies who compete with Ionis Pharmaceuticals or are related in some way:
Ionis Pharmaceuticals Dividend Yield
Data Unavailable
Ionis Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 7.3% |
Revenue: | -8.45% | -12.76% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 58.51 |
Upside from Last Price: | 26.96% |